(Q37208056)

18 August 2017

1 reference

title

Syndromes, disorders and maternal risk factors associated with neural tube defects (IV). (English)

1 reference

18 August 2017

Chih-Ping Chen

1

1 reference

PubMed ID

18603497

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

Taiwanese Journal of Obstetrics & Gynecology

18 August 2017

1 reference

18 August 2017

47

1 reference

18 August 2017

2

1 reference

18 August 2017

141-150

1 reference

Potential association between infertility and spinal neural tube defects in offspring

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovarian cysts, clomiphene therapy, and the risk of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Congenital malformations after in-vitro fertilisation

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovulation induction and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovulation induction, in-vitro fertilisation, and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovulation induction and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovulation induction and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Ovulation induction and neural tube defects: A registry study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The use of drugs in mothers of offspring with neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Risk of neural tube defects in relation to maternal fertility and fertility drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Neonatal outcome in pregnancies from ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The risk of birth defects in children born after assisted reproductive technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

In vitro fertilization is associated with an increase in major birth defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Genetics of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

THE ROLE OF FOLIC ACID IN PREGNANCY; WITH PARTICULAR REFERENCE TO ANAEMIA, ABRUPTION AND ABORTION

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Possible prevention of neural-tube defects by periconceptional vitamin supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Periconceptional use of multivitamins and the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Periconceptional folic acid exposure and risk of occurrent neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Association of neural tube defects and folic acid food fortification in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Trend in prevalence of neural tube defects in Quebec

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The Costa Rican experience: reduction of neural tube defects following food fortification programs

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Neural tube defect rates before and after food fortification with folic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folic acid fortification and cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: consideration of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folic acid fortification: is masking of vitamin B-12 deficiency what we should really worry about?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Food fortification with folic acid: has the other shoe dropped?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Is folic acid good for everyone?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Altered folate and vitamin B12 metabolism in families with spina bifida offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Vitamin B12 insufficiency and the risk of fetal neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Investigations into the etiology of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Candidate gene analysis in human neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Neural tube defects and folate: case far from closed

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Current perspectives on the genetic causes of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Etiology, pathogenesis and prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Genetic variation in genes of folate metabolism and neural-tube defect risk

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Toward understanding the genetic basis of neural tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Lack of association between mutations in the folate receptor-alpha gene and spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Molecular genetic analysis of human folate receptors in neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Analysis of the human folate receptor beta gene for an association with neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Reduced folate carrier polymorphism (80A-->G) and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD)

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Analysis of the MTHFR 1298A-->C and 677C-->T polymorphisms as risk factors for neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Susceptibility to spina bifida; an association study of five candidate genes

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c --> t methylenetetrahydrofolate reductase and 2756a --> g methionine synthase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

A Polymorphism, R653Q, in the Trifunctional Enzyme Methylenetetrahydrofolate Dehydrogenase/Methenyltetrahydrofolate Cyclohydrolase/Formyltetrahydrofolate Synthetase Is a Maternal Genetic Risk Factor for Neural Tube Defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Associations between polymorphisms within the thymidylate synthase gene and spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

Folic acid and neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2808%2960071-6

7 January 2021

10.1016/S1028-4559(08)60071-6

Identifiers

DOI

1 reference

release_hijqnnvf3bbkxer36d5ioflrgq

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hijqnnvf3bbkxer36d5ioflrgq

24 November 2022

mapped directly with Wikidata item

PubMed ID

18603497

1 reference

PubMed ID

18603497